* Mesa Laboratories Inc MLAB.OQ reported a quarterly
adjusted
loss of 26 cents per share for the quarter ended December 31,
lower than the same quarter last year, when the company reported
EPS of 39 cents. The mean expectation of four analysts for the
quarter was for earnings of $1.75 per share. Wall Street
expected results to range from $1.37 to $2.13 per share.
* Revenue rose 17.5% to $62.84 million from a year ago;
analysts
expected $58.77 million.
* Mesa Laboratories Inc's reported EPS for the quarter was a
loss
of 31 cents.
* The company reported a quarterly loss of $1.68 million.
* Mesa Laboratories Inc shares had risen by 1.6% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 24.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is "hold."
Wall Street's median 12-month price target for Mesa Laboratories
Inc is $130.00
This summary was machine generated from LSEG data February 4 at
02:51 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 1.75 -0.26 Missed
Sep. 30 2024 1.38 0.80 Missed
Jun. 30 2024 0.44 0.84 Beat
Mar. 31 2024 -0.11 3.70 Beat